Influence of Intravenous Contrast Medium on Dose Calculation Using CT in Treatment Planning for Oesophageal Cancer |
Li, Hong-Sheng
(Department of Radiation Oncology, Cancer Hospital and Institute, Tianjin Medical University)
Chen, Jin-Hu (Department of Radiation Physics, Key Laboratory of Radiation Oncology of Shandong Province, Shandong Cancer Hospital and Institute) Zhang, Wei (Department of Radiation Oncology, Cancer Hospital and Institute, Tianjin Medical University) Shang, Dong-Ping (Department of Radiation Physics, Key Laboratory of Radiation Oncology of Shandong Province, Shandong Cancer Hospital and Institute) Li, Bao-Sheng (Department of Radiation Oncology (Chest Section), Shandong Cancer Hospital and Institute) Sun, Tao (Department of Radiation Physics, Key Laboratory of Radiation Oncology of Shandong Province, Shandong Cancer Hospital and Institute) Lin, Xiu-Tong (Department of Radiation Physics, Key Laboratory of Radiation Oncology of Shandong Province, Shandong Cancer Hospital and Institute) Yin, Yong (Department of Radiation Physics, Key Laboratory of Radiation Oncology of Shandong Province, Shandong Cancer Hospital and Institute) |
1 | Choi Y, Kim JK, Lee HS, et al (2006). Influence of intravenous contrast agent on dose calculations of intensity modulated radiation therapy plans for head and neck cancer. Radiother Oncol, 81, 158-62. DOI ScienceOn |
2 | Eslick GD (2009). Epidemiology of esophageal cancer. Gastroenterol Clin North Am, 38, 17-25. DOI ScienceOn |
3 | Kamangar F, Dores GM, Anderson WF (2006). Patterns of cancer incidence, mortality, and prevalence across five continents, defining priorities to reduce cancer disparities in different geographic regions of the world. J Clin Oncol, 24, 2137-50. DOI ScienceOn |
4 | Lees J, Holloway L, Fuller M, Forstner D (2005). Effect of intravenous contrast on treatment planning system dose calculations in the lung. Australas Phys Eng Sci Med, 28, 190-5. DOI |
5 | Letourneau D, Finlay M, O'Sullivan B, et al (2008). Lack of influence of intravenous contrast on head and neck IMRT dose distributions. Acta Oncol, 47, 90-4. DOI ScienceOn |
6 | Liauw SL, Amdur RJ, Mendenhall WM, Palta J, Kim S (2005). The effect of intravenous contrast on intensity-modulated radiation therapy dose calculations for head and neck cancer. Am J Clin Oncol, 28, 456-9. DOI ScienceOn |
7 | Ramm U, Damrau M, Mose S, et al (2001). Influence of CT contrast agents on dose calculations in a 3D treatment planning system. Phys Med Biol, 46, 2631-5. DOI ScienceOn |
8 | Shibamoto Y, Naruse A, Fukuma H, Ayakawa S, Sugie C, Tomita N (2007). Influence of contrast materials on dose calculation in radiotherapy planning using computed tomography for tumors at various anatomical regions, a prospective study. Radiother Oncol, 84, 52-5. DOI ScienceOn |
9 | Shi W, Liu C, Lu B, et al (2010). The effect of intravenous contrast on photon radiation therapy dose calculations for lung cancer. Am J Clin Oncol, 33, 153-6. |
10 | Weber DC, Rouzaud M, Miralbell R (2001). Bladder opacification does not significantly influence dose distribution in conformal radiotherapy of prostate cancer. Radiother Oncol, 59, 95-7. DOI ScienceOn |
![]() |